This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...
Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...
Feb 6 (Reuters) - Cardinal Health Inc. said it reached an agreement with the U.S. Food and Drug Administration on a consent decree regarding its Alaris infusion pumps. The agreement, which is subject ...
CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).
To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback